Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US
OSSGROW is India's first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country ...
Tag: Regrow Biosciences
Picard.Law: Enterprise Legal Intelligence with Agentic Workflows
Picard.Law has launched a bold initiative to transform how legal and compliance teams manage large volumes of complex contracts by...
Read more
